Moderna (MRNA) shares dropped nearly 12% following news that FDA official Peter Marks will step down on April 5th, causing uncertainty in the biotech sector, particularly for vaccine makers.

Moderna stock has dropped more than 70% over the past year. The company’s coronavirus vaccine no longer is driving outsized growth -- and Moderna is still in the process of ushering in newer ...

See Also: Moderna’s Options: A Look at What the Big Money is Thinking Funding for the United Nations Food and Agriculture Organization is also being terminated. The report indicates that the ...

Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger ...

If you’re a home mixologist, you probably have a few bottles that are both indispensable and also often overlooked. They’re the kind of spirits, liqueurs, and ingredients that you always have ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft ...

Just keep in mind that you might not get full results from an over-the-counter cream. "Stretch marks are essentially scars and there is no way to truly get rid of scars, but there are numerous ...

In layman’s terms: it’s usually one of the first spots to show signs of aging, but adding in one of the best eye creams for mature skin to your skincare routine can help. “A medical-grade ...

Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. Whether it’s caused by acne, surgery or another wound-inducing ...